Faculty Opinions recommendation of High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study.

2006 ◽  
Author(s):  
Michael Trauner
Keyword(s):  
Ursodeoxycholic Acid ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
High Dose ◽  
Randomized Controlled

High-Dose Ursodeoxycholic Acid in Primary Sclerosing Cholangitis: A 5-Year Multicenter, Randomized, Controlled Study

2005 ◽  
Vol 129 (5) ◽  
pp. 1464-1472 ◽  
Author(s):  
Rolf Olsson ◽  
Kirsten M. Boberg ◽  
Ove Schaffalitsky de Muckadell ◽  
Stefan Lindgren ◽  
Rolf Hultcrantz ◽  
...  
Keyword(s):  
Ursodeoxycholic Acid ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
High Dose ◽  
Randomized Controlled

scholarly journals Primary sclerosing cholangitis and pregnancy

2011 ◽  
Vol 1 (3) ◽  
pp. 55 ◽  
Author(s):  
Casper Q. Kammeijer ◽  
Robert A. De Man ◽  
Christianne J.M. De Groot
Keyword(s):  
Ursodeoxycholic Acid ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Rare Case ◽  
Progressive Disease ◽  
High Dose ◽  
Term Outcome ◽  
Long Term Outcome ◽  
In Pregnancy

Primary sclerosing cholangitis is a progressive disease, and coincidentally in pregnancy it is rare. It is characterized by progressive inflammation and destruction of bile ducts finally resulting in liver failure. A rare case of primary sclerosing cholangitis in pregnancy is presented. The course of the pregnancy was marked by threatened preterm delivery and exacerbation of cholestasis. She was successfully treated with ursodeoxycholic acid (UDCA). Although, primary sclerosing cholangitis has both maternal and fetal effects on pregnancy, the overall outcome is favorable. Only few cases have been reported using high dose ursodeoxycholic acid for primary sclerosing cholangitis in pregnancy, it often improves pruritus but has no protection against stillbirth. Data on the safety to the fetus or neonate and long-term outcome are scarce.

scholarly journals High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

2012 ◽  
Vol 35 (4) ◽  
pp. 451-457 ◽  
Author(s):  
L. Lindström ◽  
K. M. Boberg ◽  
O. Wikman ◽  
I. Friis-Liby ◽  
R. Hultcrantz ◽  
...  
Keyword(s):  
Ursodeoxycholic Acid ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Colorectal Neoplasia ◽  
High Dose

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

1998 ◽  
Vol 29 (3) ◽  
pp. 417-423 ◽  
Author(s):  
Hubert J.F. Van Hoogstraten ◽  
Frank H.J. Wolfhagen ◽  
Paul C. van de Meeberg ◽  
Hillechien Kuiper ◽  
Gerard A.J.J. Nix ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Ursodeoxycholic Acid ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Controlled Trial ◽  
Acid Therapy ◽  
Randomized Controlled ◽  
Single Versus
Sign in / Sign up

Export Citation Format

Share Document